Literature DB >> 34455943

Secondary Metabolites as Treatment of Choice for Metabolic Disorders and Infectious Diseases and their Metabolic Profiling - Part 3.

Rajeev K Singla1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34455943     DOI： 10.2174/138920022206210708103019

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN： 1389-2002            Impact factor:   3.731


× No keyword cloud information.
  3 in total

Review 1.  Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies.

Authors:  Rajeev K Singla; Sahar Behzad; Johra Khan; Christos Tsagkaris; Rupesh K Gautam; Rajat Goyal; Hitesh Chopra; Bairong Shen
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

Review 2.  Translational Informatics for Natural Products as Antidepressant Agents.

Authors:  Rajeev K Singla; Shikha Joon; Li Shen; Bairong Shen
Journal:  Front Cell Dev Biol       Date:  2022-01-20

3.  Editorial: Exploration of Natural Product Leads for Multitarget-Based Treatment of Cancer-Computational to Experimental Journey.

Authors:  Rajeev K Singla; Marcus T Scotti; Supratik Kar
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.